Science Daily

Tiny implant wipes out bladder cancer in 82% of patients

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, ...
Open Access Government

Tiny bladder implant, TAR-200, eliminates cancer in 82% of patients

The TAR‑200 slow‑release bladder implant cleared tumours in 82% of patients with high‑risk non‑muscle‑invasive bladder cancer ...
Welltica+ on MSN

Tiny implant eliminates bladder cancer in 82% of patients

A new slow-release implant has shown unprecedented success in wiping out bladder cancer in more than 80 percent of patients, ...
The Lancet

Urodynamic testing in refractory overactive bladder symptoms: the FUTURE study

We read with interest the FUTURE study by Mohamed Abdel-Fattah and colleagues, which reported on the role and cost-effectiveness of urodynamic testing in women with refractory overactive bladder ...